Shares of EndoChoice Holdings Inc. (NYSE:GI) rose 3.9% during mid-day trading on Friday . The stock traded as high as $5.38 and last traded at $5.09, with a volume of 50,419 shares trading hands. The stock had previously closed at $4.90.

A number of analysts have recently weighed in on GI shares. Bank of America Corp. lowered shares of EndoChoice Holdings from a “neutral” rating to an “underperform” rating and set a $10.00 target price for the company. in a report on Thursday, March 24th. Zacks Investment Research upgraded shares of EndoChoice Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, May 10th. Finally, JPMorgan Chase & Co. started coverage on shares of EndoChoice Holdings in a report on Wednesday. They set an “overweight” rating for the company.

The firm has a 50 day moving average price of $4.55 and a 200-day moving average price of $5.18. The stock’s market capitalization is $132.40 million.

EndoChoice Holdings (NYSE:GI) last announced its quarterly earnings results on Wednesday, May 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by $0.13. The business had revenue of $18.46 million for the quarter, compared to the consensus estimate of $18.34 million. During the same quarter in the prior year, the company posted ($1.00) EPS. The business’s revenue was up 10.2% compared to the same quarter last year. Equities research analysts predict that EndoChoice Holdings Inc. will post ($2.01) EPS for the current year.

An institutional investor recently raised its position in EndoChoice Holdings stock. Bank of Montreal Can raised its position in EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned about 2.29% of EndoChoice Holdings worth $4,733,000 as of its most recent filing with the SEC.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.